Search results
Results from the WOW.Com Content Network
The settlement amount includes both the civil (False Claims Act) settlement and criminal fine. Glaxo's $3 billion settlement included the largest civil False Claims Act settlement on record, [1] and Pfizer’s $2.3 billion ($3.5 billion in 2022) settlement including a record-breaking $1.3 billion criminal fine. [2]
$1.72 billion civil ($2.2 billion with criminal component) Off-label promotion/kickbacks: False Claims Act/FDCA 2009 2 3 Bextra/Geodon/ Zyvox/Lyrica: Pfizer [7] $2,300,000,000 $1 billion civil ($2.3 billion with criminal component) Off-label promotion/kickbacks: False Claims Act/FDCA 2012 4 4 (tie) Depakote: Abbott Laboratories [8] $1,500,000,000
The following are settlements reached with US authorities against pharmaceutical companies to resolve allegations of "off-label" promotion of drugs. Under the Federal Food, Drug, and Cosmetic Act, it is illegal for pharmaceutical companies to promote their products for uses not approved by the Food and Drug Administration (FDA), and corporations that market drugs for off-label indications may ...
Trillium (TRIL) is set to be acquired by Pfizer for $2.3 billion or $18.50 per share. Stock shoots up.
In support of that goal, year-to-date, we have delevered by approximately $4.4 billion, paying down approximately $2.3 billion in maturing debt and approximately $2.1 billion in commercial paper.
Pfizer pleaded guilty to various civil and criminal charges and paid in total $2.3 billion to the government. The case netted the largest criminal fine ever imposed in the United States for any matter, $1.195 billion, [34] and the largest civil fraud settlement against any pharmaceutical company. [35]
Pfizer Inc on Tuesday said it expected 2021 sales of the COVID-19 vaccine it developed with German partner BioNTech to reach $36 billion and forecast another $29 billion from the shot in 2022 ...
[187] [188] [189] The payment included $1.195 billion in criminal penalties for felony violations of the Federal Food, Drug, and Cosmetic Act, and $1.0 billion to settle allegations it had illegally promoted the drugs for uses that were not approved by the Food and Drug Administration (FDA) leading to violations under the False Claims Act as ...